CDEK
← All organizations

Clinical Data, Inc.

For profitContributed to NME

Also known as: Clinical Data, Inc

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Sep 1, 1982

First marketed drug

Jan 21, 2011

First NDA

Jan 21, 2011

Last known activity

Sep 1, 1982

Acquired by Forest Laboratories → Actavis → Allergan PLC (2015) → AbbVie on Apr 13, 2011

Timeline

1960s

  1. Jan 1, 1969

    Clinical Data, Inc.— Founded

2000s

  1. Jan 1, 2005

    Genaissance— Acquired

2010s

  1. Jan 21, 2011

    vilazodone— NDA Organization

  2. Apr 13, 2011

    Forest Laboratories— Acquired By

  3. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (5 distinct, 2 trials)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (1)

Details

Founded
Newton, MA, US Jan 1, 1969
First NDA
Jan 21, 2011
Last known activity
Sep 1, 1982